Annals of surgical oncology · 2025
Depth of Tumor Invasion (T-Stage) is Not Associated with Survival or Recurrence Rates in Patients Undergoing Surgery for pT1 and pT2 Colon Cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hanevelt Julia, Rademaker Eva, Zamaray Bobby, Brohet Richard M, Moons Leon M G, Vleggaar Frank P, van de Laar Bart C T, Consten Esther C J, Tanis Pieter J, de Vos Tot Nederveen Cappel Wouter H, van Westreenen Henderik L, Dutch Snapshot Research Group (DSRG), Dutch Complex Colon Cancer Initiative (DCCCI)
Аннотация
BACKGROUND: Organ preservation is gaining attention, yet primary treatment approaches differ substantially between pT1 and pT2 colon cancer (CC). This study evaluates whether tumor invasion depth affects survival outcomes in patients with pT1-2N0-2 colon cancer.
METHODS: In this nationwide cohort study, patients undergoing surgery for pT1 or pT2 CC between 2014 and 2015 were identified from the Dutch Snapshot Research Group's SNAPSHOT complex colon cancer database. Five-year disease-free survival (DFS) and overall survival (OS) was analyzed using Kaplan-Meier curves, log-rank tests, and Cox proportional hazard models.
RESULTS: A total of 2312 patients were included (921 pT1 and 1391 pT2). Five-year DFS (83.5% vs. 83.2%, P = 0.79, adjusted HR [HRadj] pT2 vs. pT1: 0.9; 95% confidence interval [CI] 0.7-1.2) and 5-year OS (84.9% vs. 85.6%, P = 0.72, HRadj pT2 vs. pT1: 0.8; 95% CI 0.6-1.1) were comparable between pT1N0 and pT2N0 patients. Similarly, in pT1N+ and pT2N+ patients, there was no significant difference in DFS (81% vs. 75.8%, P = 0.31, HRadj pT2 vs. pT1: 1.3; 95% CI 0.6-2.6) or OS (84% vs. 82.5%, P = 0.73, HRadj pT2 vs. pT1: 0.9; 95% CI 0.5-1.6). Distant metastases developed in 37 (4%) pT1 patients and 68 (4.9%) pT2 patients (P = 0.33). Among these, 26 of 37 pT1 patients (70.3%) and 40 of 68 pT2 patients (58.8%) did not have lymph node metastases in the initial resection specimen (pN0).
CONCLUSIONS: Tumor invasion depth (pT1 or pT2) had no significant impact on DFS or OS following formal oncological resection. Furthermore, most distant metastases develop in pN0 patients, suggesting a minor influence of surgery on control of distant disease.
METHODS: In this nationwide cohort study, patients undergoing surgery for pT1 or pT2 CC between 2014 and 2015 were identified from the Dutch Snapshot Research Group's SNAPSHOT complex colon cancer database. Five-year disease-free survival (DFS) and overall survival (OS) was analyzed using Kaplan-Meier curves, log-rank tests, and Cox proportional hazard models.
RESULTS: A total of 2312 patients were included (921 pT1 and 1391 pT2). Five-year DFS (83.5% vs. 83.2%, P = 0.79, adjusted HR [HRadj] pT2 vs. pT1: 0.9; 95% confidence interval [CI] 0.7-1.2) and 5-year OS (84.9% vs. 85.6%, P = 0.72, HRadj pT2 vs. pT1: 0.8; 95% CI 0.6-1.1) were comparable between pT1N0 and pT2N0 patients. Similarly, in pT1N+ and pT2N+ patients, there was no significant difference in DFS (81% vs. 75.8%, P = 0.31, HRadj pT2 vs. pT1: 1.3; 95% CI 0.6-2.6) or OS (84% vs. 82.5%, P = 0.73, HRadj pT2 vs. pT1: 0.9; 95% CI 0.5-1.6). Distant metastases developed in 37 (4%) pT1 patients and 68 (4.9%) pT2 patients (P = 0.33). Among these, 26 of 37 pT1 patients (70.3%) and 40 of 68 pT2 patients (58.8%) did not have lymph node metastases in the initial resection specimen (pN0).
CONCLUSIONS: Tumor invasion depth (pT1 or pT2) had no significant impact on DFS or OS following formal oncological resection. Furthermore, most distant metastases develop in pN0 patients, suggesting a minor influence of surgery on control of distant disease.